Sonoma Pharmaceuticals (SNOA) Revenue & Revenue Breakdown
Sonoma Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$19.53M
Latest Revenue (Q)
$4.35M
Main Segment (Y)
Human Care
Main Geography (Y)
Service
Sonoma Pharmaceuticals Revenue by Period
Sonoma Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $19.53M | 36.68% |
| 2025-03-31 | $14.29M | 12.19% |
| 2024-03-31 | $12.73M | -4.05% |
| 2023-03-31 | $13.27M | 5.10% |
| 2022-03-31 | $12.63M | -32.21% |
| 2021-03-31 | $18.63M | 3.91% |
| 2020-03-31 | $17.93M | -5.49% |
| 2019-03-31 | $18.97M | 13.88% |
| 2018-03-31 | $16.66M | 29.89% |
| 2017-03-31 | $12.82M | 36.89% |
| 2016-03-31 | $9.37M | -32.37% |
| 2015-03-31 | $13.85M | 1.36% |
| 2014-03-31 | $13.67M | -11.55% |
| 2013-03-31 | $15.45M | 21.25% |
| 2012-03-31 | $12.74M | 30.65% |
| 2011-03-31 | $9.75M | 32.46% |
| 2010-03-31 | $7.36M | 36.67% |
| 2009-03-31 | $5.39M | 40.50% |
| 2008-03-31 | $3.83M | -15.58% |
| 2007-03-31 | $4.54M | 75.81% |
| 2006-03-31 | $2.58M | 90.56% |
| 2005-03-31 | $1.36M | 50.33% |
| 2004-03-31 | $902.00K | -63.48% |
| 2003-03-31 | $2.47M | 23.50% |
| 2002-03-31 | $2.00M | - |
Sonoma Pharmaceuticals generated $19.53M in revenue during NA 2026, up 36.68% compared to the previous quarter, and up 104.83% compared to the same period a year ago.
Sonoma Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $4.35M | -22.39% |
| 2025-09-30 | $5.60M | 39.58% |
| 2025-06-30 | $4.01M | 6.95% |
| 2025-03-31 | $3.75M | 5.33% |
| 2024-12-31 | $3.56M | -0.42% |
| 2024-09-30 | $3.58M | 5.54% |
| 2024-06-30 | $3.39M | -1.40% |
| 2024-03-31 | $3.44M | 9.59% |
| 2023-12-31 | $3.14M | 14.90% |
| 2023-09-30 | $2.73M | -20.31% |
| 2023-06-30 | $3.43M | 13.70% |
| 2023-03-31 | $3.01M | 2.38% |
| 2022-12-31 | $2.94M | -11.62% |
| 2022-09-30 | $3.33M | -16.37% |
| 2022-06-30 | $3.98M | 73.32% |
| 2022-03-31 | $2.30M | -20.81% |
| 2021-12-31 | $2.90M | -22.49% |
| 2021-09-30 | $3.74M | 1.63% |
| 2021-06-30 | $3.68M | 70.79% |
| 2021-03-31 | $2.16M | -56.30% |
| 2020-12-31 | $4.94M | -14.44% |
| 2020-09-30 | $5.77M | 0.03% |
| 2020-06-30 | $5.77M | 33.74% |
| 2020-03-31 | $4.31M | -1.89% |
| 2019-12-31 | $4.39M | -7.02% |
| 2019-09-30 | $4.73M | 5.16% |
| 2019-06-30 | $4.50M | 2.58% |
| 2019-03-31 | $4.38M | -17.01% |
| 2018-12-31 | $5.28M | 6.90% |
| 2018-09-30 | $4.94M | 13.05% |
| 2018-06-30 | $4.37M | 19.53% |
| 2018-03-31 | $3.65M | -24.53% |
| 2017-12-31 | $4.84M | 11.98% |
| 2017-09-30 | $4.33M | 12.78% |
| 2017-06-30 | $3.83M | -4.82% |
| 2017-03-31 | $4.03M | 19.88% |
| 2016-12-31 | $3.36M | -18.18% |
| 2016-09-30 | $4.11M | 7.79% |
| 2016-06-30 | $3.81M | 7.96% |
| 2016-03-31 | $3.53M | -7.59% |
| 2015-12-31 | $3.82M | -5.77% |
| 2015-09-30 | $4.05M | 10.16% |
| 2015-06-30 | $3.68M | -7.54% |
| 2015-03-31 | $3.98M | 23.68% |
| 2014-12-31 | $3.22M | -1.41% |
| 2014-09-30 | $3.26M | -3.77% |
| 2014-06-30 | $3.39M | 16.40% |
| 2014-03-31 | $2.91M | -11.51% |
| 2013-12-31 | $3.29M | -19.47% |
| 2013-09-30 | $4.09M | 21.26% |
| 2013-06-30 | $3.37M | 1.11% |
| 2013-03-31 | $3.33M | -5.79% |
| 2012-12-31 | $3.54M | -21.79% |
| 2012-09-30 | $4.53M | 11.73% |
| 2012-06-30 | $4.05M | 20.89% |
| 2012-03-31 | $3.35M | 20.11% |
| 2011-12-31 | $2.79M | -23.83% |
| 2011-09-30 | $3.66M | 24.59% |
| 2011-06-30 | $2.94M | 8.45% |
| 2011-03-31 | $2.71M | 17.21% |
| 2010-12-31 | $2.31M | -6.20% |
| 2010-09-30 | $2.47M | 8.92% |
| 2010-06-30 | $2.26M | 1.43% |
| 2010-03-31 | $2.23M | 38.38% |
| 2009-12-31 | $1.61M | -3.53% |
| 2009-09-30 | $1.67M | -9.47% |
| 2009-06-30 | $1.85M | 25.22% |
| 2009-03-31 | $1.48M | 20.80% |
| 2008-12-31 | $1.22M | -17.56% |
| 2008-09-30 | $1.48M | 22.30% |
| 2008-06-30 | $1.21M | 30.78% |
| 2008-03-31 | $926.00K | -13.13% |
| 2007-12-31 | $1.07M | - |
Sonoma Pharmaceuticals generated $4.35M in revenue during Q3 2026, up -22.39% compared to the previous quarter, and up 121.51% compared to the same period a year ago.
Sonoma Pharmaceuticals Revenue Breakdown
Sonoma Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Animal Care | $1.85M | $1.65M | $2.20M | - | - |
| Human Care | $17.68M | $12.08M | $10.11M | - | - |
| Service And Royalty | - | $556.00K | $422.00K | - | - |
| Shipping and Handling | - | - | - | $42.00K | $52.00K |
| Service | - | - | - | - | $349.00K |
Sonoma Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Mar 26: Human Care (90.54%), and Animal Care (9.46%).
Quarterly Revenue by Product
| Product/Service | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Care | $874.00K | $486.00K | $488.00K | $875.00K | $376.00K | $402.00K | $1.09M | $621.00K | $489.00K | $414.00K | $818.00K | $1.00M | $812.00K | $1.36M | $951.00K | - | - | - | - | - |
| Human Care | $8.70M | $3.86M | $5.12M | $6.07M | $3.05M | $2.96M | $5.57M | $2.46M | $2.08M | $1.81M | $2.02M | $2.59M | $2.71M | $3.53M | $4.78M | - | - | - | - | - |
| Product | - | - | - | $4.01M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Service And Royalty | - | - | - | - | $200.00K | $136.00K | $220.00K | $199.00K | $56.00K | $167.00K | $69.00K | $148.00K | $157.00K | - | - | - | - | - | - | - |
| Service | - | - | - | - | - | - | - | - | - | - | $99.00K | $75.00K | $147.00K | $1.03M | - | - | - | - | - | - |
| Other Sales | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $45.00K | $42.00K |
Sonoma Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Human Care (90.87%), and Animal Care (9.13%).
Sonoma Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 22 |
|---|---|
| Service | $349.00K |
| Shipping and Handling | $52.00K |
Sonoma Pharmaceuticals's latest annual revenue breakdown by geography, as of Mar 22: Service (87.03%), and Shipping and Handling (12.97%).
Quarterly Revenue by Country
| Country | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|
| Latin America | $1.31M | $2.02M | $2.32M |
| UNITED STATES | $1.98M | $1.98M | $1.72M |
| Europe and Rest of the World | $1.65M | $1.76M | $3.21M |
Sonoma Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 20: UNITED STATES (40.07%), Europe and Rest of the World (33.45%), and Latin America (26.48%).